The Patent Finder

Neurodevelopmental Disorder Therapy

Anavex Life Sciences Corp.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2017/014702, filed Jan 24, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,507,196Neurodevelopmental Disorder Therapy
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 10,888,543Neurodevelopmental Disorder Therapy
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 11,446,275Neurodevelopmental Disorder Therapy
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 11,839,600Neurodevelopmental Disorder Therapy
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
US 12,734,147Neurodevelopmental Disorder Therapy
In force
 · High confidence
Anavex Life Sciences Corp.In force
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited